Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus

We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of obstetrics & gynecology and reproductive biology 1998-08, Vol.79 (2), p.227-229
Hauptverfasser: Somerset, David A, Raine-Fenning, Nicholas, Gordon, Caroline, Weaver, Judith B, Kilby, Mark D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 229
container_issue 2
container_start_page 227
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 79
creator Somerset, David A
Raine-Fenning, Nicholas
Gordon, Caroline
Weaver, Judith B
Kilby, Mark D
description We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.
doi_str_mv 10.1016/S0301-2115(98)00070-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73853800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211598000700</els_id><sourcerecordid>73853800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-dac31ec515e4d75f34a90ad39c7220f93546b700efd6e528e4bbdfc3f1ef75803</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxi0EKtvCI1TKASF6CNhxvHZOqKr4U6kSB-BsOfaka5TYweMU7Svw1Di7q71ysGzN_GY-zzeEXDP6nlG2_fCdcsrqhjHxrlM3lFJJa_qMbJiSTS23on1ONmfkJblE_FUgynl3QS462VDVqg35ex9yMk8Q4oKVn6YlxMcx9svoQ5V3kMy8r8rTxmlOcfIIrpoTPAYTrAesDGK03uQS_uPzrjIh-3kXsZzRz94dAn10Bza4CveYYfK2Gpe5CELaF5HJ5IgLviIvBjMivD7dV-Tn508_7r7WD9--3N_dPtSWqy7XzljOwAomoHVSDLw1HTWOd1Y2DR06LtptLymFwW1BNAravneD5QODQQpF-RV5e-xbJvq9AGZd5rIwjiZAcUFLrgRXdAXFEbQpIiYY9Jz8ZNJeM6rXHejDDvRqsO6UPuxAr3XXJ4Gln8Cdq06ml_ybU96gNeOQVjPxjDVN1wouC_bxiEEx48lD0lg8DxacT2CzdtH_5yP_ABZqqIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73853800</pqid></control><display><type>article</type><title>Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Somerset, David A ; Raine-Fenning, Nicholas ; Gordon, Caroline ; Weaver, Judith B ; Kilby, Mark D</creator><creatorcontrib>Somerset, David A ; Raine-Fenning, Nicholas ; Gordon, Caroline ; Weaver, Judith B ; Kilby, Mark D</creatorcontrib><description>We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/S0301-2115(98)00070-0</identifier><identifier>PMID: 9720848</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Antiphospholipid syndrome ; Antiphospholipid Syndrome - therapy ; Biological and medical sciences ; Female ; Fetal compromise ; Humans ; Immunoglobulins, Intravenous - therapeutic use ; Immunomodulators ; Intravenous immunoglobulin ; Lupus Erythematosus, Systemic - therapy ; Medical sciences ; Pharmacology. Drug treatments ; Pregnancy ; Pregnancy Complications - therapy ; Systemic lupus erythematosus</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 1998-08, Vol.79 (2), p.227-229</ispartof><rights>1998 Elsevier Science Ireland Ltd</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-dac31ec515e4d75f34a90ad39c7220f93546b700efd6e528e4bbdfc3f1ef75803</citedby><cites>FETCH-LOGICAL-c389t-dac31ec515e4d75f34a90ad39c7220f93546b700efd6e528e4bbdfc3f1ef75803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0301-2115(98)00070-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2294537$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9720848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Somerset, David A</creatorcontrib><creatorcontrib>Raine-Fenning, Nicholas</creatorcontrib><creatorcontrib>Gordon, Caroline</creatorcontrib><creatorcontrib>Weaver, Judith B</creatorcontrib><creatorcontrib>Kilby, Mark D</creatorcontrib><title>Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.</description><subject>Adult</subject><subject>Antiphospholipid syndrome</subject><subject>Antiphospholipid Syndrome - therapy</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Fetal compromise</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunomodulators</subject><subject>Intravenous immunoglobulin</subject><subject>Lupus Erythematosus, Systemic - therapy</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - therapy</subject><subject>Systemic lupus erythematosus</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQxi0EKtvCI1TKASF6CNhxvHZOqKr4U6kSB-BsOfaka5TYweMU7Svw1Di7q71ysGzN_GY-zzeEXDP6nlG2_fCdcsrqhjHxrlM3lFJJa_qMbJiSTS23on1ONmfkJblE_FUgynl3QS462VDVqg35ex9yMk8Q4oKVn6YlxMcx9svoQ5V3kMy8r8rTxmlOcfIIrpoTPAYTrAesDGK03uQS_uPzrjIh-3kXsZzRz94dAn10Bza4CveYYfK2Gpe5CELaF5HJ5IgLviIvBjMivD7dV-Tn508_7r7WD9--3N_dPtSWqy7XzljOwAomoHVSDLw1HTWOd1Y2DR06LtptLymFwW1BNAravneD5QODQQpF-RV5e-xbJvq9AGZd5rIwjiZAcUFLrgRXdAXFEbQpIiYY9Jz8ZNJeM6rXHejDDvRqsO6UPuxAr3XXJ4Gln8Cdq06ml_ybU96gNeOQVjPxjDVN1wouC_bxiEEx48lD0lg8DxacT2CzdtH_5yP_ABZqqIA</recordid><startdate>19980801</startdate><enddate>19980801</enddate><creator>Somerset, David A</creator><creator>Raine-Fenning, Nicholas</creator><creator>Gordon, Caroline</creator><creator>Weaver, Judith B</creator><creator>Kilby, Mark D</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980801</creationdate><title>Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus</title><author>Somerset, David A ; Raine-Fenning, Nicholas ; Gordon, Caroline ; Weaver, Judith B ; Kilby, Mark D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-dac31ec515e4d75f34a90ad39c7220f93546b700efd6e528e4bbdfc3f1ef75803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Antiphospholipid syndrome</topic><topic>Antiphospholipid Syndrome - therapy</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Fetal compromise</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunomodulators</topic><topic>Intravenous immunoglobulin</topic><topic>Lupus Erythematosus, Systemic - therapy</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - therapy</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Somerset, David A</creatorcontrib><creatorcontrib>Raine-Fenning, Nicholas</creatorcontrib><creatorcontrib>Gordon, Caroline</creatorcontrib><creatorcontrib>Weaver, Judith B</creatorcontrib><creatorcontrib>Kilby, Mark D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Somerset, David A</au><au>Raine-Fenning, Nicholas</au><au>Gordon, Caroline</au><au>Weaver, Judith B</au><au>Kilby, Mark D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>1998-08-01</date><risdate>1998</risdate><volume>79</volume><issue>2</issue><spage>227</spage><epage>229</epage><pages>227-229</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9720848</pmid><doi>10.1016/S0301-2115(98)00070-0</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 1998-08, Vol.79 (2), p.227-229
issn 0301-2115
1872-7654
language eng
recordid cdi_proquest_miscellaneous_73853800
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Antiphospholipid syndrome
Antiphospholipid Syndrome - therapy
Biological and medical sciences
Female
Fetal compromise
Humans
Immunoglobulins, Intravenous - therapeutic use
Immunomodulators
Intravenous immunoglobulin
Lupus Erythematosus, Systemic - therapy
Medical sciences
Pharmacology. Drug treatments
Pregnancy
Pregnancy Complications - therapy
Systemic lupus erythematosus
title Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A45%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20immunoglobulin%20therapy%20in%20compromised%20pregnancies%20associated%20with%20antiphospholipid%20antibodies%20and%20systemic%20lupus%20erythematosus&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Somerset,%20David%20A&rft.date=1998-08-01&rft.volume=79&rft.issue=2&rft.spage=227&rft.epage=229&rft.pages=227-229&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/S0301-2115(98)00070-0&rft_dat=%3Cproquest_cross%3E73853800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73853800&rft_id=info:pmid/9720848&rft_els_id=S0301211598000700&rfr_iscdi=true